Vericel Corp Ord
Yahoo Finance • 3 days ago
US High Growth Tech Stocks to Watch for Potential Expansion
As the United States stock market continues to reach new heights, with major indices like the S&P 500 and Nasdaq Composite posting consecutive weeks of gains, investors are paying close attention to high-growth sectors such as technology.... Full story
Yahoo Finance • 28 days ago
Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025
CAMBRIDGE, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will participate in a fireside c... Full story
Yahoo Finance • last month
Velo3D stock soars after participating in U.S. Army funded initiative
Investing.com -- Velo3D, Inc. (NASDAQ:VELO) stock surged 31% after the company announced its participation in a U.S. Army-funded initiative to advance high-throughput aluminum manufacturing for defense applications. The additive manufactu... Full story
Yahoo Finance • 2 months ago
Vericel Corp (NASDAQ: VCEL) Posts Mixed Q2 2025 Results with Revenue Miss and EPS Beat
VERICEL CORP (NASDAQ: VCEL [https://www.chartmill.com/stock/quote/VCEL]) REPORTS MIXED Q2 2025 RESULTS AS REVENUE MISSES ESTIMATES, EPS BEATS Vericel Corp released its second-quarter 2025 financial results, revealing a mixed performance r... Full story
Yahoo Finance • 2 months ago
Vericel GAAP EPS of -$0.01 beats by $0.02, revenue of $63.24M misses by $1.25M
* Vericel press release [https://seekingalpha.com/pr/20184663-vericel-reports-second-quarter-2025-financial-results] (NASDAQ:VCEL [https://seekingalpha.com/symbol/VCEL]): Q2 GAAP EPS of -$0.01 beats by $0.02. * Revenue of $63.24M (+20.... Full story
Yahoo Finance • 2 months ago
Vericel Reports Second Quarter 2025 Financial Results
Total Revenue Growth of 20% to $63.2 Million, with MACI Revenue Growth of 21% to $53.5 Million Gross Margin Increased More than 400 Basis Points to 74% Adjusted EBITDA Growth of 112% to $13.4 Million, with Adjusted EBITDA Margin Increase... Full story
Yahoo Finance • 2 months ago
Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025
CAMBRIDGE, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will report its second-quarter 2... Full story
Yahoo Finance • 2 months ago
Vericel stock hits 52-week low at $37.38 amid market challenges
Vericel (NASDAQ:VCEL) Corp’s stock has reached a new 52-week low, trading at $37.38. This marks a significant downturn for the company, which has seen its stock value decrease by 28.23% over the past year. Despite the decline, InvestingPro... Full story
Yahoo Finance • 3 months ago
Vericel at 2025 Truist Securities MedTech Conference: Growth Strategies Unveiled
On Tuesday, 17 June 2025, Vericel Corp (NASDAQ:VCEL) took center stage at the 2025 Truist Securities MedTech Conference, offering a strategic overview of its growth initiatives. CEO Nick Colangelo and CFO Joe Mara outlined the company’s fo... Full story
Yahoo Finance • 4 months ago
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025
CAMBRIDGE, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will participate in a fireside c... Full story
Yahoo Finance • 5 months ago
Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025
CAMBRIDGE, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will present at the Bank of Ameri... Full story
Yahoo Finance • 7 months ago
Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results
Full-Year Total Revenue Growth of 20% to $237.2 Million, with MACI Revenue Growth of 20% and Burn Care Revenue Growth of 22% Full-Year Adjusted EBITDA Growth of 58% to $53.4 Million Record Fourth Quarter Gross Margin of 78%, Adjusted EBI... Full story
Yahoo Finance • 7 months ago
Vericel to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 27, 2025
CAMBRIDGE, Mass., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will report its fourth-quarter a... Full story
Yahoo Finance • 12 months ago
Vericel Corp (VCEL) Q2 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ...
Total Revenue: $52.7 million for the second quarter. MACI Revenue: $44.1 million, a 21% increase year-over-year. Burn Care Revenue: $8.5 million, including Epicel revenue of $7.8 million and NexoBrid revenue of $0.8 million. Gross Margin:... Full story
Yahoo Finance • last year
Vericel Corporation (NASDAQ:VCEL) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Last week, you might have seen that Vericel Corporation (NASDAQ:VCEL) released its quarterly result to the market. The early response was not positive, with shares down 9.0% to US$47.62 in the past week. Revenues came in at US$53m, in line... Full story
Yahoo Finance • 2 years ago
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance
Vericel Corporation Full-Year 2023 Total Revenue Growth of 20% to $197.5 Million, with Adjusted EBITDA Growth of 40% Fourth Quarter Total Revenue Growth of 23% to $65.0 Million, with Adjusted EBITDA Growth of 50% Fourth Quarter Gross Ma... Full story
Yahoo Finance • 2 years ago
Insider Sell: COO Michael Halpin Sells 17,447 Shares of Vericel Corp (VCEL)
Vericel Corp (NASDAQ:VCEL), a leader in the field of regenerative medicine, has recently witnessed a significant insider transaction. The company's Chief Operating Officer, Michael Halpin, sold 17,447 shares on November 30, 2023. This move... Full story
Yahoo Finance • 2 years ago
Vericel Corporation (NASDAQ:VCEL) Q3 2023 Earnings Call Transcript
Vericel Corporation (NASDAQ:VCEL) Q3 2023 Earnings Call Transcript November 8, 2023 Vericel Corporation beats earnings expectations. Reported EPS is $-0.08, expectations were $-0.13. Operator: Ladies and gentlemen, thank you for standing... Full story
Yahoo Finance • 2 years ago
Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
Record Third Quarter Revenue of $45.6 Million, Representing 18% Growth versus Prior Year MACI Revenue Growth of 21% to $37.6 Million Full-Year 2023 Revenue Guidance Raised to $192.5-197.5 Million Conference Call Today at 8:30am Eastern... Full story
Yahoo Finance • 2 years ago
Vericel to Present at the Stephens Annual Investment Conference
CAMBRIDGE, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO and Joe Ma... Full story
